Podcasts

Gene Editing Complexities with Tom McCauley, PhD

Emily Walsh Martin, PhD - January 16, 2024

Tom McCauley, PhD (Omega Therapeutics) joins Emily Walsh Martin, PhD to explore the next generation of molecular therapeutics on the second episode of The Issue, available now on the ASGCT Podcast Network.

Follow the ASGCT Podcast Network wherever you listen to podcasts!

     

Episode 2 of The Issue on the ASGCT podcast network is an in-depth interview with Tom McCauley, PhD, CSO of Omega Therapeutics. Tom and Emily talk about his path from condensed matter physics to leading teams of scientists exploring the next generation of molecular therapeutics. They also dive into their mutual experience in the early days of in vivo gene editing and the challenges one faces with the complexities of these products, particularly before there is much of a roadmap for development. Finally, they dive into the recent public Ad Comm and ultimate approval of Casgevy and how we hope the industry continues to evolve and set standards as we move forward novel approaches.

Music by: https://www.steven-obrien.net/
--------------------------
Bright New Morning - Steven O'Brien

(Used for free under a Creative Commons Attribution 4.0 License: https://creativecommons.org/licenses/by/4.0/)

Related Articles

Podcasts

CMC Strategy with Susan D'Costa, PhD—The Issue

Listen now on the ASGCT Podcast Network! - April 16, 2024
Podcasts

CAR T for Acute Myeloid Leukemia with Dr. Marco Davila—Molecular Therapy Podcast

Listen now! - April 09, 2024
Podcasts

Regulatory Landscapes in CGT with Sabrina Mogle—ASGCT's The Issue

Listen now! - March 26, 2024
Podcasts

Hear Drs. David Schaffer and Adam Schieferecke on the Molecular Therapy Podcast

Listen now! - March 12, 2024